FAP and neoplasm: Hu et al. developed fibroblast activation protein-α (FAP) gene–engineered tumor cell-derived exosome-like nanovesicles (eNVs-FAP) as tumor-based vaccines that inhibited tumor growth by remodeling the tumor microenvironment and promoting tumor cell ferroptosis [114].